Dysregulation of lipid metabolism in NAFLD leads to intrahepatic CD4 + T lymphocyte loss selectively, implying that NAFLD patients have lower LYMPH profiles than those without NAFLD [59]. The gene discussed is CD4; the disease is metabolic dysfunction-associated steatotic liver disease.